Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c16037b7e000e7f04283e4a0f2ed382 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91057 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91235 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94 |
filingDate |
2002-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e25786affe3526d5cfb663638f691a2 |
publicationDate |
2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-03028631-A2 |
titleOfInvention |
Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism |
abstract |
Target molecules for the development of assays and screening of compound libraries, which will be used to develop therapeutics for the prevention and treatment of Alzheimer's disease and other diseases associated with decreased neuronal metabolism are provided. Also provided are methods of treatment for the diseases. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2150265-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005024058-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245325-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005024058-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2150265-A4 |
priorityDate |
2001-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |